Nanotech sets sail

This week, Planktos, a nanotech company with the lofty goal of reducing carbon emissions, finally set sail. Planktos aims to reduce carbon emissions by releasing huge amounts of iron into the ocean, with the hope that plankton will take up that iron, and absorb more carbon. According to the New York Times, Planktos' 115-foot ship, the WeatherBird II, linkurl:launched from Florida;http://dotearth.blogs.nytimes.com/2007/11/06/project-to-harness-plankton-puts-to-sea/index.html on Sunday (Novem

Written byAlison McCook
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
This week, Planktos, a nanotech company with the lofty goal of reducing carbon emissions, finally set sail. Planktos aims to reduce carbon emissions by releasing huge amounts of iron into the ocean, with the hope that plankton will take up that iron, and absorb more carbon. According to the New York Times, Planktos' 115-foot ship, the WeatherBird II, linkurl:launched from Florida;http://dotearth.blogs.nytimes.com/2007/11/06/project-to-harness-plankton-puts-to-sea/index.html on Sunday (November 4). In this month's issue, bioethics columnist linkurl:Glenn McGee;http://www.the-scientist.com/2007/11/1/33/1/ expressed concerns about Planktos, arguing that the technology is too much of a question mark to be deemed safe. Early findings weren't encouraging, and scientists and environmentalists have dismissed the company's claims. What are the long-term implications of releasing this plankton? How will the current carry the particles? How will this massive amount of extra iron affect plankton plumes? McGee asked. Looks like we may soon find out.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies